Migraine drugs
Pro Research Analysisby 
Searched over 200M research papers for "migraine drugs"
Migraine Drugs: A Comprehensive Overview
Introduction to Migraine Treatment
Migraine is a prevalent and disabling neurological condition that significantly impacts the quality of life of sufferers. Effective management of migraines involves both acute and preventive pharmacological strategies, tailored to individual patient needs and characteristics 28.
Acute Migraine Treatment: Effective Medications
Triptans and NSAIDs
Triptans, including almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, and zolmitriptan, are highly effective for acute migraine treatment (Level A evidence) . Non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin, diclofenac, ibuprofen, and naproxen are also recommended for acute attacks .
Other Acute Medications
Dihydroergotamine (nasal spray, inhaler) and ergotamine are probably effective (Level B evidence) . Additionally, acetaminophen, sumatriptan/naproxen, and the combination of acetaminophen/aspirin/caffeine are effective options (Level A evidence) . For severe attacks, intravenous acetylsalicylic acid or subcutaneous sumatriptan are first-choice drugs .
Preventive Migraine Treatment: Established and Emerging Options
Established Preventive Medications
Beta-blockers (propranolol, metoprolol), flunarizine, valproic acid, and topiramate are first-line drugs for migraine prophylaxis . Amitriptyline, naproxen, petasites, and bisoprolol are considered second-choice options . Antiepileptic drugs like valproate and topiramate are effective and well-tolerated for migraine prevention 510.
New and Emerging Preventive Agents
Recent advances have introduced monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) or its receptor, such as rimegepant and atogepant, which show promise for both acute and preventive treatment . Other emerging options include lamotrigine for preventing aura, riboflavin, gabapentin, magnesium, and botulinum toxin A, although more rigorous data are needed to confirm their efficacy .
Mechanisms of Action and Drug Development
The development of migraine therapeutics has expanded significantly, with a focus on novel targets such as CGRP receptors and 5HT1F agonists like lasmiditan 24. Understanding the pharmacodynamic and pharmacokinetic properties of these drugs is crucial for optimizing treatment strategies .
Conclusion
The landscape of migraine treatment is continually evolving, with a range of effective acute and preventive medications available. Established drugs like triptans, NSAIDs, beta-blockers, and antiepileptics remain mainstays, while new agents targeting specific migraine pathways offer promising alternatives. Clinicians must consider efficacy, side effects, and patient preferences when tailoring migraine therapy.
Sources and full results
Most relevant research papers on this topic